Deep Track Capital as of Dec. 31, 2021
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 53 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Keros Therapeutics (KROS) | 5.4 | $76M | 1.3M | 58.51 | |
| Travere Therapeutics (TVTX) | 5.4 | $76M | 2.5M | 31.04 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 4.7 | $67M | 1.1M | 60.87 | |
| Iveric Bio | 4.7 | $67M | 4.0M | 16.72 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 4.5 | $64M | 500k | 127.40 | |
| Global Blood Therapeutics In | 4.1 | $59M | 2.0M | 29.27 | |
| Beam Therapeutics (BEAM) | 3.9 | $56M | 700k | 79.69 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.8 | $54M | 1.9M | 28.41 | |
| Repare Therapeutics Ord (RPTX) | 3.1 | $44M | 2.1M | 21.09 | |
| Madrigal Pharmaceuticals (MDGL) | 3.0 | $42M | 500k | 84.74 | |
| 4d Molecular Therapeutics In (FDMT) | 2.9 | $42M | 1.9M | 21.94 | |
| Novocure Ord Shs (NVCR) | 2.9 | $41M | 550k | 75.08 | |
| Immunovant (IMVT) | 2.9 | $41M | 4.8M | 8.52 | |
| Chinook Therapeutics | 2.8 | $40M | 2.4M | 16.31 | |
| Sage Therapeutics Call Option (SAGE) | 2.7 | $38M | 900k | 42.54 | |
| Kura Oncology (KURA) | 2.5 | $36M | 2.6M | 14.00 | |
| Dice Therapeutics | 2.4 | $34M | 1.3M | 25.31 | |
| Jounce Therapeutics | 2.4 | $33M | 4.0M | 8.35 | |
| Esperion Therapeutics (ESPR) | 2.0 | $28M | 5.6M | 5.00 | |
| Dyne Therapeutics (DYN) | 1.9 | $27M | 2.3M | 11.89 | |
| Miragen Therapeutics (VRDN) | 1.9 | $26M | 1.3M | 19.77 | |
| Fate Therapeutics (FATE) | 1.7 | $25M | 418k | 58.51 | |
| Avidity Biosciences Ord (RNA) | 1.7 | $24M | 1.0M | 23.77 | |
| ACADIA Pharmaceuticals Call Option (ACAD) | 1.6 | $23M | 1.0M | 23.34 | |
| Gritstone Oncology Ord (GRTS) | 1.6 | $23M | 1.8M | 12.86 | |
| Silence Therapeutics Ads (SLN) | 1.6 | $23M | 951k | 23.89 | |
| Tricida | 1.6 | $22M | 2.3M | 9.56 | |
| Magenta Therapeutics | 1.5 | $22M | 4.9M | 4.43 | |
| Passage Bio (PASG) | 1.4 | $20M | 3.2M | 6.35 | |
| Kalvista Pharmaceuticals (KALV) | 1.4 | $20M | 1.5M | 13.23 | |
| Nkarta (NKTX) | 1.4 | $19M | 1.3M | 15.35 | |
| Verve Therapeutics (VERV) | 1.3 | $18M | 500k | 36.87 | |
| Karuna Therapeutics Ord | 1.2 | $17M | 130k | 131.00 | |
| Vanda Pharmaceuticals (VNDA) | 1.1 | $16M | 1.0M | 15.69 | |
| Tenaya Therapeutics (TNYA) | 1.0 | $14M | 762k | 18.95 | |
| Protagonist Therapeutics (PTGX) | 1.0 | $14M | 422k | 34.20 | |
| Fulcrum Therapeutics (FULC) | 0.9 | $13M | 750k | 17.69 | |
| Sierra Oncology Com New | 0.9 | $13M | 608k | 21.74 | |
| Acumen Pharmaceuticals (ABOS) | 0.9 | $13M | 1.9M | 6.76 | |
| Atara Biotherapeutics | 0.8 | $12M | 750k | 15.76 | |
| Gh Research Ordinary Shares (GHRS) | 0.8 | $12M | 499k | 23.33 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $11M | 80k | 134.53 | |
| Atyr Pharma Com New (ATYR) | 0.6 | $8.2M | 1.1M | 7.47 | |
| Assembly Biosciences | 0.5 | $7.0M | 3.0M | 2.33 | |
| Nektar Therapeutics Put Option (NKTR) | 0.5 | $6.8M | 500k | 13.51 | |
| Bridgebio Pharma Call Option (BBIO) | 0.5 | $6.7M | 400k | 16.68 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.3 | $4.5M | 400k | 11.26 | |
| Avrobio Ord (AVRO) | 0.3 | $4.0M | 1.1M | 3.85 | |
| Century Therapeutics (IPSC) | 0.3 | $4.0M | 250k | 15.86 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.2 | $3.3M | 647k | 5.15 | |
| Oncorus | 0.2 | $3.2M | 600k | 5.27 | |
| Alnylam Pharmaceuticals Put Option (ALNY) | 0.1 | $2.0M | 12k | 169.57 | |
| Rafael Hldgs Com Cl B (RFL) | 0.1 | $1.5M | 286k | 5.10 |
